Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Nicholas R. Wawrzyniak, Anna-Maria Joseph, David G. Levin, David M. Gundermann, Christiaan Leeuwenburgh, Bhanuprasad Sandesara, Todd M. Manini, Peter J. Adhihetty
Published Jul 18, 2016 · Vol. 7, No. 33 · pp. 52695-52709
Elena Martinez-Garcia, Antoine Lesur, Laura Devis, Alexandre Campos, Silvia Cabrera, Jan van Oostrum, Xavier Matias-Guiu, Antonio Gil-Moreno, Jaume Reventos, Eva Colas, Bruno Domon
Published Jul 16, 2016 · Vol. 7, No. 33 · pp. 53102-53115
Pedro Castelo-Branco, Ricardo Leão, Tatiana Lipman, Brittany Campbell, Donghyun Lee, Aryeh Price, Cindy Zhang, Abolfazl Heidari, Derek Stephens, Stefan Boerno, Hugo Coelho, Ana Gomes, Celia Domingos, Joana D. Apolonio, Georg Schäfer, Robert G. Bristow, Michal R. Schweiger, Robert Hamilton, Alexandre Zlotta, Arnaldo Figueiredo, Helmut Klocker, Holger Sültmann, Uri Tabori
Published Jul 16, 2016 · Vol. 7, No. 36 · pp. 57726-57736